Back to PE Pentwater Capital Management LP

STROSTRO
21 quarters

Position history for PEPentwater Capital Management LP's holdings in SUTRO BIOPHARMA INC

No. Pentwater Capital Management exited its STRO (Sutro Biopharma) position in Q1 2024. Its Q4 2023 13F listed 450,000 shares worth $1.9M. Pentwater Capital Management already held STRO in its Q1 2019 13F, the earliest on record, and held it in 20 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1.4M

Total Shares Change

-127,005

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q1
Latest
Exited
0
-100.0%
$00.0%$56.50
0
2023-Q4
Increased
450,000
+4.7%
$1.9M0.0%$42.90
27
2023-Q3
Increased
430,000
+7.5%
$1.5M0.0%$34.70
27
2023-Q2
Increased
400,000
+56.9%
$1.9M0.0%$46.50
37
2023-Q1
Increased
255,000
+13.3%
$1.2M0.0%$44.80
29
2022-Q4
Decreased
225,000
-37.5%
$1.8M0.0%$80.80
0
2022-Q3
Decreased
360,000
-5.3%
$2M0.0%$54.30
0
2022-Q2
Increased
380,000
+52.0%
$2M0.0%$52.40
36
2022-Q1
Increased
250,000
+8.7%
$2.1M0.0%$81.40
28
2021-Q4
Increased
230,000
+9.5%
$3.4M0.0%$150.60
29
2021-Q3
Unchanged
210,000
0.0%
$4M0.0%$186.50
0
2021-Q2
Increased
210,000
+13.8%
$3.9M0.0%$181.60
30
2021-Q1
Decreased
184,501
-35.1%
$4.2M0.0%$210.40
0
2020-Q4
Decreased
284,501
-24.1%
$6.2M0.1%$218.30
0
2020-Q3
Decreased
375,000
-1.8%
$3.8M0.0%$102.90
0
2020-Q2
Increased
382,026
+413.6%
$3M0.1%$78.70
43
2020-Q1
Decreased
74,385
-6.9%
$759,0000.0%$102.50
0
2019-Q4
Decreased
79,892
-10.3%
$879,0000.0%$110.40
0
2019-Q3
Decreased
89,081
-10.9%
$810,0000.0%$93.30
0
2019-Q2
Decreased
100,000
-21.3%
$1.1M0.0%$113.80
0
2019-Q1
First report
127,005
-
$1.4M0.0%$113.90
0

Other major holders of STRO: FRANKLIN TEMPLETON INC, STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used